Yi et al. also investigated combinations of these markers with and without IGFBP3; however, significant results were only reported for the two smaller populations of TNM stage I–IV colon cancer patients (n = 147, n = 72) [48]. The gene discussed is IGFBP3; the disease is malignant colon neoplasm.